On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Brain Metastases and Treatment

TopicLeading institutions, researchers & key papers

Brain Metastases and Treatment is a topic indexed in ScholarIQ from OpenAlex.

What is known about Brain Metastases and Treatment?

ScholarIQrecord summary

This cluster of papers focuses on the management of brain metastases in cancer patients, including the use of radiosurgery and whole-brain radiation therapy, the impact on cognitive function, prognostic assessment, blood-brain barrier permeability, and specific considerations for HER2-positive breast cancer. It also explores the role of immunotherapy, the effects on neurocognitive function, and the challenges associated with leptomeningeal metastasis.

How many works does Brain Metastases and Treatment have?

ScholarIQindexed works

Brain Metastases and Treatment has 218 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Brain Metastases and Treatment?

ScholarIQopenalex

The OpenAlex for Brain Metastases and Treatment is on the source record.

What are the most-cited papers on Brain Metastases and Treatment?

ScholarIQmost cited works
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
David W. Andrews, Charles Scott, Paul W. Sperduto, Adam E. Flanders, Laurie E. Gaspar, Michael C. Schell, Maria Werner‐Wasik, William F. Demas, Janice Ryu, Jean-Paul Bahary, Luís Souhami, Marvin Rotman, Minesh P. Mehta, Walter J. Curran
The Lancet. 20042,429 Citations
Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases
Paul D. Brown, Kurt A. Jaeckle, Karla V. Ballman, Elana Farace, Jane H. Cerhan, S. Keith Anderson, Xiomara W. Carrero, Fred G. Barker, Richard L. Deming, Stuart H. Burri, Cynthia Ménard, Caroline Chung, Volker W. Stieber, Bruce E. Pollock, Evanthia Galanis, Jan C. Buckner, Anthony L. Asher
JAMA. 20161,673 CitationsOPEN ACCESS
A New Prognostic Index and Comparison to Three Other Indices for Patients With Brain Metastases: An Analysis of 1,960 Patients in the RTOG Database
Paul W. Sperduto, Brian Berkey, Laurie E. Gaspar, Minesh P. Mehta, Walter J. Curran
International Journal of Radiation Oncology*Biology*Physics. 20071,048 Citations
Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study
Georgina V. Long, Victoria Atkinson, Serigne Lo, Shahneen Sandhu, Alexander Guminski, Michael P. Brown, James S. Wilmott, Jarem Edwards, Maria Gonzalez, Richard A. Scolyer, Alexander M. Menzies, Grant A. McArthur
The Lancet Oncology. 20181,001 Citations
Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial
Nancy U. Lin, Virginia F. Borges, Carey K. Anders, Rashmi K. Murthy, Elisavet Paplomata, Erika Hamilton, Sara A. Hurvitz, Sherene Loi, Alicia Okines, Vandana G. Abramson, Philippe L. Bédard, Mafalda Oliveira, Volkmar Müller, Amelia Zelnak, Michael P. DiGiovanna, Thomas Bachelot, A. Jo Chien, Ruth O’Regan, Andrew Wardley, Alison Conlin, David Cameron, Lisa A. Carey, Giuseppe Curigliano, Karen A. Gelmon, Sibylle Loibl, JoAl Mayor, Suzanne McGoldrick, Xuebei An, Eric P. Winer
Journal of Clinical Oncology. 2020556 CitationsOPEN ACCESS

Where is Brain Metastases and Treatment research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock

How much of the research on Brain Metastases and Treatment is open access?

ScholarIQopen access share
60%OPEN ACCESS
Gold
0%
Green
7%
Hybrid
40%
Bronze
13%
Closed
40%

Related on ScholarIQ

470M+ articles · 14-day free trial